e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman
Source:
Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
Journal Issue:
June
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman. Interdisciplinary multimodality management of stage III nonsmall cell lung cancer. Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013
Management of stage I and II nonsmall cell lung cancer
Source: Eur Respir J 2017; 49(1): 1600764; DOI: 10.1183/13993003.00764-2016
Year: 2017
Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021
Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006
Radiotherapy with curative intent for stage I and II non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Management of locally advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 260–270
Year: 2009
International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019
Year: 2020
Radiotherapy for stage III non-small cell lung cancer (NSCLC)
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021
First- and second-line therapy for advanced nonsmall cell lung cancer
Source: Eur Respir J 2009; 33: 915-930
Year: 2009
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Year: 2021
Adjuvant chemotherapy in stage Ib of non-small cell lung cancer (NSCLC)-experience of a pneumology department
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
The treatment of stage IV non-small cell lung cancer with target therapies
Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Year: 2013
Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Adjuvant chemotherapy in stage IB nonsmall cell lung cancer
Source: Breathe 2009; 5: 361
Year: 2009
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept